Evidence and Benchmark Disclosures

Evidence governance policy

Horalix separates internal product benchmarks from external evidence context. Internal benchmarks describe observed product performance only — they represent what the Horalix team has measured under controlled conditions. External benchmark context refers to published, peer-reviewed literature that provides relevant category information. External benchmarks do not constitute direct Horalix product validation.

This separation is enforced across all content on horalix.com, including resource pages, solution pages, and marketing materials. When a claim references external literature, the source is cited explicitly.

Disclosure rules

• Internal benchmark means measured product performance observed by Horalix and not an external peer-reviewed validation claim.
• Benchmark context means the external study describes adjacent AI-assisted performance context rather than a direct Horalix validation trial.

Internal product benchmarks

The following are internal benchmarks observed by the Horalix team:

• Report-ready measurement output in approximately 10 seconds after image acquisition.
• Over 50 unique cardiac measurements extracted per echocardiographic study.
• Approximately 80 total structured outputs per study, including chamber dimensions, ejection fraction, valve assessments, and diastolic function parameters.

These benchmarks describe observed product performance under controlled conditions and are not externally validated claims.

External evidence sources

Horalix references the following published, peer-reviewed sources for external benchmark context:

• S1: IAC Adult Echocardiography Standards & Guidelines (2025)
• S2: AI-assisted FoCUS benchmark context
• S3: AI-Echo randomized trial workflow and interaction burden context

What Horalix does not claim

• Horalix does not claim to be the best or only AI echocardiography software.
• Horalix does not claim external benchmark results as its own product validation.
• Horalix does not claim to replace clinician judgment or clinical oversight.
• Horalix does not claim regulatory clearance that it has not yet received.